India DST Offers Low-Interest Loans For Drug R&D Projects
This article was originally published in PharmAsia News
Executive Summary
India's Department of Science and Technology is offering low-interest loans to drug makers who submit research-and-development proposals for pharmaceutical products. The DST loans are available to the drug industry, academic institutions and national laboratories at three percent interest after the approved project is completed. The loan offer is open throughout the year, with each approved project expected to take 100 days for processing. (Click here for more
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.